Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 21 - Oct 26
The modified peptide contains 2 Aib substitutions at positions 2 and 20 with a molecular weight of 4.5 kDa
Moreover, it hinders the ARE and NF-B signaling pathways, leading to lower generation of pro-inflammatory factors
No particles
FDA-reviewed clinical trials found that participants receiving tirzepatide alongside dietary changes and increased physical activity experienced greater weight reduction than those receiving a placebo
Table 1 summarizes the prominent GLP-1 receptor agonists and related dual agonists: Exenatide (Byetta, Bydureon): A synthetic exendin-4 peptide (from Gila monster venom) and the first GLP-1 RA (approved 2005)
US$ 24.76
US$ 22.70
US$ 27.97
US$ 25.53
US$ 27.14
US$ 21.45
US$ 27.11
US$ 23.80
